(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one-D4; (5?)-17-(Cyclopropyl-methyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one-D4; Antaxone-D4; Depade-D4; EN 1639A-D4; NIH 8503-D4; Nalorex-D4; Trexan-D4
Naltrexone-d4 is a fully characterized chemical compound used as a reference standard of API Naltrexone. The standard offered is compliant with regulatory guidelines. Naltrexone-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 16590-41-3 (non-labelled)
